SCHEMBL7257919

SCHEMBL7257919

COc1ccc(-c2c3nc(cc4[nH]c(c(O)c4O)c(-c4ccc(NC(C)=O)cc4)c4nc(cc5[nH]c2c(O)c5O)CC4)CC3)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MTNR1A P48039 3/20 0.41
▸ MTNR1B P49286 3/20 0.41
▸ FYN P06241 1/20 0.41
▸ DYRK1A Q13627 1/20 0.40
▸ DYRK1B Q9Y463 1/20 0.40
▸ SLC2A1 P11166 1/20 0.39
▸ ITK Q08881 1/20 0.39
▸ SMN1; SMN2 Q16637 1/20 0.39
▸ HSP90AA1 P07900 1/20 0.39
▸ ADORA3 P0DMS8 2/20 0.38
▸ MEN1 O00255 1/20 0.38
▸ MAPT P10636 1/20 0.38
▸ KMT2A Q03164 1/20 0.38
▸ JAK1 P23458 1/20 0.38
▸ BRAF P15056 1/20 0.38
▸ ALDH1A1 P00352 1/20 0.38
▸ HPGD P15428 1/20 0.38
▸ ACHE P22303 1/20 0.38
▸ ALK Q9UM73 1/20 0.38
▸ IDO1 P14902 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7257922 0.86 STAT3 (0.37) MTNR1AMTNR1BFYNDYRK1ADYRK1B
SCHEMBL7260982 0.84 ALDH1A1 (0.40) SMN1; SMN2HSP90AA1MEN1MAPTKMT2A
SCHEMBL7259678 0.76 ITK (0.40) MTNR1AMTNR1BFYNDYRK1ADYRK1B
SCHEMBL7262946 0.71 STAT3 (0.40) SMN1; SMN2MEN1KMT2AALDH1A1HPGD
SCHEMBL171415 0.67 SMN1; SMN2 (0.73) MTNR1AMTNR1BSMN1; SMN2MEN1MAPT
SCHEMBL27267778 0.67 SMN1; SMN2 (0.73) MTNR1AMTNR1BSMN1; SMN2MEN1MAPT
SCHEMBL7258044 0.65 STAT3 (0.49) MTNR1AMTNR1BFYNDYRK1ADYRK1B
SCHEMBL9571811 0.65 MTNR1A (0.71) MTNR1AMTNR1BSLC2A1SMN1; SMN2MEN1
SCHEMBL27627516 0.65 SMN1; SMN2 (0.70) MTNR1AMTNR1BSMN1; SMN2MEN1MAPT
Fluoride SCHEMBL28166192 0.65 SMN1; SMN2 (0.70) MTNR1AMTNR1BSMN1; SMN2MEN1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030203888-A1 Chromophores WELLCOME TRUST LIMITED, THE (GB) 2003-10-30 — — US disclosed
EP-1294726-A2 IMPROVEMENTS IN AND RELATING TO CHROMOPHORES Catalyst Biomedica Ltd (GB) 2003-03-26 — — EP disclosed
WO-2002000662-A1 IMPROVEMENTS IN AND RELATING TO CHROMOPHORES CATALYST BIOMEDICA LIMITED (GB) 2002-01-03 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030203888-A1 Chromophores HCCS, PPOX, HMBS MTNR1A 2928/4885MTNR1B 2441/4885FYN 4730/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback